Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings].
D006801:Humans; D019964:Mood Disorders / Q000503:physiopathology*; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D010830:Physostigmine / Q000494:pharmacology
D010830:Physostigmine